WAT Medical launches EmeTerm Smart anti-nausea smartwatch campaign on Indiegogo
WAT Medical has launched its EmeTerm Smart anti-nausea smartwatch campaign on Indiegogo after years of research and development. The health-improving smartwatch actively counters nausea and vomiting in various scenarios by using electrical stimulation of an acupuncture point on the wrist.
The human body is connected by a network of nerves that transmit sensations such as pressure or pain felt across the body to the brain. The sensations are transmitted as electrical signals that can be manipulated using external electrical stimuli, or transcutaneous electrical nerve stimulation (TENS). Acupuncture is a well-known practice used in traditional Chinese medicine to help alleviate pain, nausea, and other symptoms of poor health.
The EmeTerm watch specifically stimulates the pericardium 6 acupuncture point (PC6) to prevent nauseating stomach muscle contractions as a transcutaneous electrical acupuncture point stimulation (TEAS) device. The advantage of this wearable is its drug-free relief of nausea and vomiting. The smartwatch has received FDA 510(k) clearance for this purpose for users six years and older. The watch can be used while riding in a car, train, plane, or boat, and during pregnancy or after surgeries.
The degree of relief will vary depending on the user, but one post-operative study showed that the incidence of postoperative nausea and vomiting caused by anesthetics 24 hours after surgery was reduced by approximately 26% among EmeTerm wearers. Naturally, all medical treatments can have side-effects, and 5 out of 260 study patients (~1.9%) experienced localized allergies or unbearable numbness.
The EmeTerm Smart can be used to count daily steps in addition to telling the time. The waterproof watch is IP67-rated and can be used while swimming or on a boat. The rechargeable battery powers the watch for up to 20 hours while countering nausea and up to 72 hours in watch mode. The watch recharges in 2 hours using the included USB-A charging cable. The watch measures 2.36 x 2.36 x 1.77 inches (60 x 60 x 45 mm) and weighs 1.6 ounces (48.5 g). The wristband is sized for wrist diameters of 5.12 to 7.87 inches (130 to 200 mm).
The EmeTerm Smart anti-nausea watch is currently priced at $139 as a Super Early Bird special on Indiegogo. Readers who can't wait for the smartwach to arrive before a nauseating ride or surgery can pick up motion sickness pills on Amazon.
Are you a techie who knows how to write? Then join our Team! Wanted:
- News Writer (Romania based)
- Proofreader
Details here
Source(s)
Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo
News provided by
WAT Medical Enterprise Ltd.
Aug 08, 2024, 11:00 ET
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world's first anti-nausea smart watch.
EmeTerm® Smart's story is one of heartfelt innovation. In 2010, the founder's wife experienced severe morning sickness during her pregnancy. Frustrated by the lack of effective, drug-free solutions, he was inspired to create a device that could help not only his wife but also countless others suffering from nausea. Driven by love and determination, he assembled a team of passionate and experienced professionals who shared his vision and founded WAT Medical, a Canadian medical technology company, in 2015.
Since its establishment, WAT Medical has dedicated years to developing high-precision, wearable medical devices to prevent debilitating conditions like nausea, migraines, and obesity. Co-founder, Peter Ji, who holds a Doctorate in Optometry from the University of California, Berkeley, states that the entire team firmly believes in the integration of advanced technology and patient-centered care to make a positive impact on the global medical landscape. In alignment with this vision, WAT Medical actively fulfills its social responsibilities by contributing to esteemed organizations such as M.D. Anderson Cancer Center, the Canadian Red Cross, and Peace Arch Hospital. Furthermore, WAT Medical supports vulnerable groups, including veterans and patients with rare conditions such as EDS and HDS, through various charitable initiatives.
Today, WAT Medical is proud to introduce a new smart device that exceeds expectations and transforms lives. The EmeTerm® Smart anti-nausea wristband utilizes transcutaneous electrical nerve stimulation (TENS) to provide a drug-free, side-effect-free solution for all types of nausea and vomiting. FDA-approved and boasting a success rate of up to 85%, EmeTerm® Smart effectively combats nausea in a safe and natural manner.[1]
Additionally, a study published in the British Journal of Anesthesia (BJA) confirms that wearable TENS wristbands can effectively prevent postoperative nausea and vomiting. On February 27, 2023, Ohio State University further validated its efficacy through testing and analysis of both subjective patient responses and objective physiological data.
The new EmeTerm® Smart model also stands out with its smart features. Users can adjust the electrical stimulation level via a touch-sensitive screen with a clear interface. Moreover, it offers timekeeping and step counting to help users better understand and improve their health. With an IP67 waterproof rating, EmeTerm® Smart can stay submerged in 1-meter-deep water for 30 minutes and is completely protected from dust, ensuring it can be used in various situations.
EmeTerm® Smart will be released via Indiegogo in August 2024. The MSRP is $299, with early backers enjoying up to 39% off. Visit the EmeTerm® Smart's Indiegogo page to learn more: Indiegogo page.
[1] Wang N, Ding P, Zheng D Y, et al. Wearable transcutaneous electrical acupoint stimulation bracelet for prevention of postoperative nausea and vomiting in patients undergoing hysteroscopic surgery: a randomised controlled trial[J]. British Journal of Anaesthesia, 2022, 129(4): e85-e87. www.bjanaesthesia.org.uk/article/S0007-0912(22)00348-8/fulltext
Media Contact:
Company Name: WAT Medical
Contact: EmeTerm
Email: [email protected]
Website: EmeTerm
SOURCE WAT Medical Enterprise Ltd.